Compare DYN & SXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DYN | SXT |
|---|---|---|
| Founded | 1984 | 1882 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 5.7B |
| IPO Year | 2020 | 1994 |
| Metric | DYN | SXT |
|---|---|---|
| Price | $25.99 | $137.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 3 |
| Target Price | $37.00 | ★ $121.00 |
| AVG Volume (30 Days) | ★ 1.9M | 316.5K |
| Earning Date | 05-04-2026 | 04-24-2026 |
| Dividend Yield | N/A | ★ 1.36% |
| EPS Growth | N/A | ★ 7.48 |
| EPS | N/A | ★ 2.24 |
| Revenue | N/A | ★ $1,396,499,000.00 |
| Revenue This Year | N/A | $8.99 |
| Revenue Next Year | N/A | $9.45 |
| P/E Ratio | ★ N/A | $60.07 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $11.92 | $82.60 |
| 52 Week High | $27.31 | $136.58 |
| Indicator | DYN | SXT |
|---|---|---|
| Relative Strength Index (RSI) | 56.32 | 68.88 |
| Support Level | $16.45 | $109.48 |
| Resistance Level | $26.96 | N/A |
| Average True Range (ATR) | 0.97 | 3.40 |
| MACD | -0.18 | 0.37 |
| Stochastic Oscillator | 41.11 | 97.20 |
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
Sensient Technologies Corp manufactures and markets natural and synthetic colors, flavors, and other specialty ingredients. Sensient's offerings are predominantly applied to consumer-facing products, including food and beverage, cosmetics and pharmaceuticals, nutraceuticals, and personal care industries. Its principal products are flavors, flavor enhancers, ingredients, extracts, and bionutrients, essential oils, dehydrated vegetables and other food ingredients, natural and synthetic food and beverage colors, and others. The company's reportable segments are: Flavors & Extracts, which derive key revenue, Color, Asia Pacific, and Corporate and Other. Geographically, the company generates maximum revenue from North America, followed by Europe, Asia-Pacific, and other regions.